The Cav1.2 L-Type Calcium Channel Regulates Bone Homeostasis in the Middle and Inner Ear T ⁎ Chike Caoa, , Aaron B
Total Page:16
File Type:pdf, Size:1020Kb
Bone 125 (2019) 160–168 Contents lists available at ScienceDirect Bone journal homepage: www.elsevier.com/locate/bone Full Length Article The CaV1.2 L-type calcium channel regulates bone homeostasis in the middle and inner ear T ⁎ Chike Caoa, , Aaron B. Oswaldb, Brian A. Fabellab, Yinshi Renc,d, Ramona Rodriguize, George Trainorf, Matthew B. Greenblattg,h, Matthew J. Hiltonc,d, Geoffrey S. Pitta a Cardiovascular Research Institute, Weill Cornell Medical College, 413 East 69th St., New York, NY 10021, USA b Howard Hughes Medical Institute and Laboratory of Sensory Neuroscience, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA c Department of Orthopaedic Surgery, Duke University School of Medicine, 450 Research Drive, Durham, NC 27710, USA d Department of Cell Biology, Duke University School of Medicine, 450 Research Drive, Durham, NC 27710, USA e Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University School of Medicine, 308 Research Drive, Durham, NC 27708, USA f Harrington Discovery Institute, Innovation Support Center, 2103 Cornell Road, Cleveland, OH 44106, USA g Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10021, USA h Research Division, Hospital for Special Surgery, New York, NY 10021, USA ARTICLE INFO ABSTRACT Keywords: Bone remodeling of the auditory ossicles and the otic capsule is highly restricted and tightly controlled by the CaV1.2 osteoprotegerin (OPG)/receptor activator of nuclear factor kappa-Β ligand (RANKL)/receptor activator of nu- 2+ Ca signaling clear factor kappa-Β (RANK) system. In these bony structures, a pathological decrease in OPG expression sti- Osteoprotegerin mulates osteoclast differentiation and excessive resorption followed by accrual of sclerotic bone, ultimately Otosclerosis resulting in the development of otosclerosis, a leading cause of deafness in adults. Understanding the signaling Osteoclast pathways involved in maintaining OPG expression in the ear would shed light on the pathophysiology of oto- sclerosis and other ear bone-related diseases. We and others previously demonstrated that Ca2+ signaling 2+ through the L-type CaV1.2 Ca channel positively regulates OPG expression and secretion in long bone os- teoblasts and their precursor cells in vitro and in vivo. Whether CaV1.2 regulates OPG expression in ear bones has TS not been investigated. We drove expression of a gain-of-function CaV1.2 mutant channel (CaV1.2 ) using Col2a1-Cre, which we found to target osteochondral/osteoblast progenitors in the auditory ossicles and the otic TS capsule. Col2a1-Cre;CaV1.2 mice displayed osteopetrosis of these bones shown by μCT 3D reconstruction, histological analysis, and lack of bone sculpting, findings similar to phenotypes seen in mice with an osteoclast TS defect. Consistent with those observations, we found that Col2a1-Cre;CaV1.2 mutant mice showed reduced osteoclasts in the otic capsule, upregulated mRNA expression of Opg and Opg/Rankl ratio, and increased mRNA expression of osteoblast differentiation marker genes in the otic capsule, suggesting both an anti-catabolic and TS anabolic effect of CaV1.2 mutant channel contributed to the observed morphological changes of the ear bones. TS Further, we found that Col2a1-Cre;CaV1.2 mice experienced hearing loss and displayed defects of body balance 2+ in behavior tests, confirming that the CaV1.2-dependent Ca influx affects bone structure in the ear and con- sequent hearing and vestibular functions. Together, these data support our hypothesis that Ca2+ influx through TS CaV1.2 promotes OPG expression from osteoblasts, thereby affecting bone modeling/remodeling in the au- ditory ossicles and the otic capsule. These data provide insight into potential pathological mechanisms under- lying perturbed OPG expression and otosclerosis. 1. Introduction the cochlea and vestibular system. In the otic capsule, the vibrations are converted into electrical signals and transduced to the brain via audi- The middle ear contains the three auditory ossicles—the malleus, tory nerves [1]. Abnormal morphological changes of the bone struc- incus, and stapes—which sequentially conduct sound by transmitting tures in the auditory ossicles or the otic capsule may disturb sound sound vibrations from the tympanic membrane to the fluid in the co- transmission and cause conductive hearing loss and/or vestibular dys- chlea via the oval window of the otic capsule, the bony case enclosing function. ⁎ Corresponding author. E-mail address: [email protected] (C. Cao). https://doi.org/10.1016/j.bone.2019.05.024 Received 28 January 2019; Received in revised form 1 May 2019; Accepted 18 May 2019 Available online 20 May 2019 8756-3282/ © 2019 Elsevier Inc. All rights reserved. C. Cao, et al. Bone 125 (2019) 160–168 The auditory ossicles and the otic capsule, unlike most bones in the roles for CaV1.2 in many non-excitable cells. We and others demon- skull that form through intramembranous ossification, develop like long strated that CaV1.2 was expressed in osteoblast progenitors during long bones through endochondral ossification. In this process an initial bone development and homeostasis [25–27]. Moreover, in an in vitro cartilage template is subsequently replaced by bone while the termin- MC3T3-E1 cell and a primary calvaria organ culture system, Ca2+ ally differentiated hypertrophic chondrocytes and the calcified cartilage signaling through CaV1.2 regulated OPG expression [28]. Pharmaco- matrix are removed by osteoclasts (bone modeling phase) [2,3]. Ab- logical blocking of CaV1.2 channel activity with nifedipine reduced the sence of osteoclastic bone resorption in mice with osteoclast defects level of OPG expression and secretion [28]. Consistent with those TS results in osteopetrotic phenotype of these bones, significantly affecting findings, we exploited the TS-causing mutant channel (CaV1.2 )to their morphology and function [4]. However, unlike long bones, no increase Ca2+ signaling specifically in osteoblasts or their progenitors significant bone remodeling (a coupled process of osteoclastic bone and observed inhibited osteoclast activity in long bones through upre- resorption with subsequent osteoblastic formation) occurs in the audi- gulated OPG expression and secretion [25]. tory ossicles or the otic capsule after development [5]. Turnover of the Given its ability to modulate the OPG/RANKL/RANK pathway, we otic capsule in regions surrounding the perilymph spaces is about hypothesized that CaV1.2 could also affect bone modeling in the ear. 2+ TS 0.13% per year compared to 10% for the long bones [6]. This low bone Here, we show that increased Ca signaling through CaV1.2 ex- remodeling rate in the otic capsule is due to high levels of secreted pressed in the auditory ossicles and the otic capsule affected bone osteoprotegerin (OPG) [7,8], a major negative regulator of osteoclas- modeling/remodeling as well as auditory and vestibular function. 2+ togenesis and consequent bone resorption. By binding RANKL (receptor Defining the role of Ca signaling through CaV1.2 in the physiological activator of NFκB ligand) [9], OPG acts as a decoy receptor and pre- regulation of osteoclast formation offers insights into the mechanisms vents RANKL-RANK interactions and the downstream RANK-mediated underlying the pathophysiology of otosclerosis and other bony dis- nuclear factor kappa B (NFκB) activation that is critical for initiation of orders of the ear and provides clues for future explorations of ther- − − osteoclast differentiation. In Opg / mice, massive erosion of auditory apeutic strategies or prevention of hearing loss caused by bony struc- ossicles and the otic capsule by unchecked osteoclasts leads to com- tural changes in the middle and inner ear. pensatory abnormal osteogenesis, causing fixation of the stapes and consequent progressive hearing loss [10,11]. 2. Materials and methods In humans, reduced OPG in the otic capsule is associated with otosclerosis [12,13], a condition characterized by abnormal growth of 2.1. Experimental mouse models bone at one or more foci within the middle ear or inner ear that often leads to hearing loss in patients. Otosclerosis develops initially through All animals were handled according to protocols approved by the a first phase of bone resorption by activated osteoclasts and increased Institutional Animal Care and Use Committee at Duke University and at TS vascularization (the otospongiosis phase), followed by new bone de- Weill Cornell Medical College. Rosa26-CaV1.2 and Col2a1-Cre have TS position from osteoblasts and mineralization (the otosclerosis phase) been described previously [29–31]. Homozygous Rosa26-CaV1.2 fe- [13]. The prevalence of otosclerosis is high in Caucasians compared to male mice were crossed with Col2a1-Cre males to generate Col2a1- TS patients of African descent and higher in women than men [14]. The Cre;CaV1.2 mutant progeny and Cre-negative littermate controls [31] etiology of otosclerosis is not well understood, but both genetic and with both sexes used in all experiments. environmental factors, including measles virus infection, hormonal changes during pregnancy and middle ear inflammation, have been 2.2. X-gal staining postulated to contribute. Family linkage analyses and candidate gene association studies have identified several loci associated with oto- X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) staining sclerosis, yet none of the otosclerosis causing genes within these regions was performed on whole mount specimens. The auditory ossicles, the has been identified so far [15–17]. Nevertheless, mutations in SER- inner ear vestibular system and cochlea were fixed in 4% paraf- PINF1 or MEPE have been recently associated with familial otosclerosis ormaldehyde on ice for 1 h, washed three times with 1 x PBS, and [18,19]. Given that maintaining OPG level is fundamental to the pre- stained with X-gal solution (5 mM potassium ferrocyanide, 5 mM po- vention of bone turnover in the middle and inner ear and the con- tassium ferricyanide, 1 mg/ml X-gal, 2 mM MgCl2, 0.1% sodium deox- sequent development of otosclerosis, a better understanding of the ycholate, 0.2% IGEPAL CA-630) in the dark for 12 h at 37 °C.